Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL PET: Exercise + Regadenoson for PET MPI
NCT01109992Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2011
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD), sponsored by Brigham and Women's Hospital. Started Feb 2011; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01109992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109992.